Iberdomide in combination with dexamethasone and daratumumab, bortezomib, or carfilzomib in RRMM patients
Iberdomide in combination with dexamethasone and daratumumab, bortezomib, or carfilzomib in RRMM patients
Should every transplant eligible NDMM patient receive a transplant?
Vaccinations in myeloma patients including for COVID-19
Culture, Community and Communication in Advanced Disease in India
OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021
The role of the medical oncologist in the holistic care of patients with cancer in the Philippines
Current state of prostate cancer in Antigua and Barbuda
OncoAlert and ecancer weekly round up for August 2 - August 14, 2021
Predicting survival in NSCLC patients with poor performance status in resource-constrained settings
Telemedicine in cancer care during and beyond the pandemic: defining a place beyond acute need
ecancer Symposium: Low Middle- Income Countries vs. High- Income Countries: Cancer Care
OncoAlert and ecancer weekly round up for July 19 - July 25, 2021